Population
Patients presenting with cardiomyopathy or cardiac arrhythmogenic disease with potential underlying…
Design
Review
Authors
Loading...
May support neuromuscular evaluation in cardiomyopathy; leaves open prospective validation of expanded genetic panels.
Highlights the importance of investigating for underlying neuromuscular disorders in patients presenting with cardiomyopathy or cardiac arrhythmogenic disease, as 25% of cardiomyopathy genes also cause neuromuscular disorders.
Anna Kostareva (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: